Cathie Wood acquired 33M Recursion Pharmaceuticals shares worth $149M. That's 1.09% of their equity portfolio (27th largest holding). The investor owns 7.42% of the outstanding Recursion Pharmaceuticals stock. The first Recursion Pharmaceuticals trade was made in Q2 2021. Since then Cathie Wood bought shares eleven more times and sold shares on five occasions. The investor's estimated purchase price is $318M, resulting in a loss of 53%.
Recursion Pharmaceuticals (NASDAQ: RXRX ) is one of the high-flying stocks gaining focus in today¡¯s market. Indeed, shares of RXRX stock are rocketing more t...
Cathie Wood just gave the company a huge vote of confidence.